Put Options on STAA on 5/6/2019

STAAR Surgical Company (STAA) designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.

The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery.

In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. 

Shares have broken below a support following the company's latest report. Lower share prices are expected for this stock.

We will be trading May 17 Put Options

Last Trade: $25.00

Trading Range: $21.70 - $54.00

Trade Buy 1 May $25.00 Put at $1.10 For a net debit of $1.10 Profit/Loss Analysis Breakeven at $23.90 Maximum profit is unbounded Maximum loss is ($110.00) at strike of $25.00 Closing Summary Sold 1 May $25.00 Put at $1.00

Position closed on 5/17/2019 at price of $1.00 with a -9.09% loss in 11 days.

Updates

5/17/2019 9:38:14 AM

STAA put closed at $1.00

Back to Portfolio